Global Health Asia-Pacific Issue 5 | 2022 Issue 5 | 2022 | Page 96

MEDICAL

FERTILITY CENTRE OF THE YEAR IN ASIA PACIFIC

VIRTUS FERTILITY CENTRE SINGAPORE ( VFCS )
VFCS began operations in 2015 in a purpose-built , dedicated in vitro fertilisation ( IVF ) facility together with a team of fertility specialists , embryologists , and specially trained nurses with a vision to improve patient outcomes .
VFCS is one of the centres in Virtus Health , an Australian company and the fourth largest provider of IVF services globally , and its mission is to provide personal fertility services enhanced by the passion of people and the precision of technology by creating a culture with the ambition to continually deliver the best care , science , and outcomes .
VFCS is proud to have a unique ‘ clean room ’ embryology laboratory and automated radiofrequency identification , thereby providing optimal safety , service quality assurance , and peace of mind for their patients .
The IVF centre is conveniently located near Singapore ’ s commercial area and has dedicated andrology and embryology laboratories , so everything is done on site within the clinic .
The clinical team works closely with dedicated fertility coaches to help couples cope with the stress as they undergo IVF . The positivity and calm assurance that they are not alone help pave the way for smoother cycles and better outcomes .
The team at VFCS strives to improve clinical outcomes by adopting the latest technologies and knowledge in IVF . Their collaborative approach to fertility care gives patients confidence that the entire team is working together to give them the best possible chance of
Dr Liow Swee Lian
success .
Success rates are rising annually . In 2021 , VFCS achieved a clinical pregnancy rate of 67 percent per transfer for patients under 30 . Patients between 31 to 34 saw a 62 percent clinical pregnancy rate while those between 35 to 39 , a 55 percent rate . The majority of patients are between 35 to 45 .
VFCS combines high magnification technology that can identify and select sperm with good DNA integrity with intra-cytoplasmic sperm injection ( ICSI ) to improve embryo quality and pregnancy outcomes . In addition , VFCS also employs Polarised Light
Microscopy ( PLM ) to identify healthy eggs for fertilisation . This is particularly useful for more mature patients where genetic abnormalities are more common and eggs are fewer .
The premise is to ‘ Make Every Egg Count ’ and use innovation to better understand a patient ’ s egg quality , thereby optimising outcomes . Sperm analysis has always been emphasised at VFCS as well , and equal care is taken to select each sperm for the ICSI process .
To optimise workflow and minimise the exposure of the embryos by frequent assessment , VFCS uses a timelapse incubation system which allows the process of embryo development to be continually monitored without disrupting their environment . This process is further enhanced by using artificial intelligence and visual assessments to help determine which embryos are more likely to succeed in producing a viable pregnancy .
In 2022 , VFCS expanded its clinical capacity to better serve its patients and providers . It remains committed to serving its patients with empathy and a mindset of excellence in every step of their journey . VFCS recognises that sometimes it takes a village to start a family . Their medical team consider themselves ‘ Your Fertility Family ’ – a dedicated and compassionate resource for patients to turn to when starting a family becomes hard to do .
VFCS is committed and continues to work with its colleagues within the Virtus Health group of IVF centres and other IVF centres to support patients ’ various needs .
94 ISSUE 5 | 2022 GlobalHealthAsiaPacific . com